DK76191D0 - Filamentoest haemagglutinin fra b.pertussis - Google Patents

Filamentoest haemagglutinin fra b.pertussis

Info

Publication number
DK76191D0
DK76191D0 DK91761A DK76191A DK76191D0 DK 76191 D0 DK76191 D0 DK 76191D0 DK 91761 A DK91761 A DK 91761A DK 76191 A DK76191 A DK 76191A DK 76191 D0 DK76191 D0 DK 76191D0
Authority
DK
Denmark
Prior art keywords
pertussis
therapy
filamentoest
haemagglutinin
filamentous hemagglutinin
Prior art date
Application number
DK91761A
Other languages
English (en)
Other versions
DK76191A (da
Inventor
David A Relman
Mario Domenighini
Rino Rappuoli
Stanley Falkow
Original Assignee
Univ Leland Stanford Junior
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Sclavo Spa filed Critical Univ Leland Stanford Junior
Publication of DK76191D0 publication Critical patent/DK76191D0/da
Publication of DK76191A publication Critical patent/DK76191A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/127RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Rotary Switch, Piano Key Switch, And Lever Switch (AREA)
  • Insulated Conductors (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK076191A 1988-10-27 1991-04-25 Filamentoest haemagglutinin fra b.pertussis DK76191A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26364888A 1988-10-27 1988-10-27
PCT/US1989/004732 WO1990004641A1 (en) 1988-10-27 1989-10-20 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS)

Publications (2)

Publication Number Publication Date
DK76191D0 true DK76191D0 (da) 1991-04-25
DK76191A DK76191A (da) 1991-06-14

Family

ID=23002666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK076191A DK76191A (da) 1988-10-27 1991-04-25 Filamentoest haemagglutinin fra b.pertussis

Country Status (9)

Country Link
EP (1) EP0439542B1 (da)
JP (1) JPH04501506A (da)
AT (1) ATE176913T1 (da)
AU (1) AU643190B2 (da)
CA (1) CA1341123C (da)
DE (1) DE68928933T2 (da)
DK (1) DK76191A (da)
FI (1) FI911973A0 (da)
WO (1) WO1990004641A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643753A (en) 1990-04-18 1997-07-01 Connaught Laboratories Limited Use of autologous promoters to express gene products in bordetella
GB9008746D0 (en) * 1990-04-18 1990-06-13 Connaught Lab The use of autologous promoters to express gene products in bordetella
DE4111531A1 (de) * 1991-04-09 1992-10-29 Biotechnolog Forschung Gmbh Plasmide zur fha-expression und wirte
WO1994021816A1 (en) * 1993-03-25 1994-09-29 Envirocon International Incorporated Test kits and methods for rapidly testing for contamination by microorganisms
US5646251A (en) * 1993-11-05 1997-07-08 The Board Of Trustees Of Leeland Stanford Jr. Univ. Alloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamily
FR2718750B1 (fr) * 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
EP1069133A1 (en) 1999-07-13 2001-01-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neisseria meningitidis compounds and anti-infection applications thereof
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
US8916173B2 (en) 2013-03-08 2014-12-23 Crucell Holland B.V. Acellular pertussis vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine

Also Published As

Publication number Publication date
ATE176913T1 (de) 1999-03-15
EP0439542A4 (en) 1991-11-06
JPH04501506A (ja) 1992-03-19
WO1990004641A1 (en) 1990-05-03
AU643190B2 (en) 1993-11-11
EP0439542A1 (en) 1991-08-07
DE68928933D1 (de) 1999-04-01
CA1341123C (en) 2000-10-17
EP0439542B1 (en) 1999-02-24
DE68928933T2 (de) 1999-08-26
FI911973A0 (fi) 1991-04-23
AU4515589A (en) 1990-05-14
DK76191A (da) 1991-06-14

Similar Documents

Publication Publication Date Title
IT8224948A0 (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo.
ATE229978T1 (de) Helicobacter proteine und impstoffe
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
DK76191D0 (da) Filamentoest haemagglutinin fra b.pertussis
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
FI924457A (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
ATE422900T1 (de) Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
HU9200583D0 (en) Method for producing el peptides of rubeola
DE69013621D1 (de) Verfahren zur Herstellung von tertiärem Amino-Alkohol.
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
DK1077999T3 (da) Moraxella catarrhalis-proteiner
DE60126490D1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
NO911673L (no) Filament - hemagglutinin av b. pertussis.
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
ATE206138T1 (de) Helicobacter pylori antigen
NO912823L (no) Fremgangsmaate for fremstilling av klasse ii-proteinet av neisseria meningitidis samt vaksiner som inneholder dette.
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
NO864382D0 (no) Midler for forbedring av proteinabsorpsjon.
IT1213576B (it) Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.